OBJECTIVE: To determine the change in parental ratings of executive function and behavior in children with primary hypertension after anti-hypertensive therapy. STUDY DESIGN: Parents of subjects with untreated hypertension and control subjects completed the Behavior Rating Inventory of Executive Function (BRIEF) to assess behavioral correlates of executive function and the Child Behavior Checklist (CBCL) to assess internalizing and externalizing behaviors. Subjects with hypertension subsequently received anti-hypertensive therapy to achieve casual blood pressure (BP)<95th percentile. After 12 months, all parents again completed the BRIEF and CBCL. RESULTS: Twenty-two subjects with hypertension and 25 normotensive control subjects underwent both baseline and 12-month assessments. The BP of subjects with hypertension improved (24-hour systolic BP [SBP] load: mean baseline versus 12-months, 60% versus 25%, P<.001). Parent ratings of executive function improved from baseline to 12 months in the subjects with hypertension (BRIEF Global Executive Composite T-score, Delta=-5.9, P=0.001), but not in the normotensive control subjects (Delta=-0.36, P=.83). In contrast, T-scores on the CBCL Internalizing and Externalizing summary scales did not change significantly from baseline to 12 months in either subjects with hypertension or control subjects. CONCLUSIONS: Children with hypertension demonstrated improvement in parental ratings of executive function after 12 months of anti-hypertensive therapy. Copyright (c) 2010 Mosby, Inc. All rights reserved.
OBJECTIVE: To determine the change in parental ratings of executive function and behavior in children with primary hypertension after anti-hypertensive therapy. STUDY DESIGN: Parents of subjects with untreated hypertension and control subjects completed the Behavior Rating Inventory of Executive Function (BRIEF) to assess behavioral correlates of executive function and the Child Behavior Checklist (CBCL) to assess internalizing and externalizing behaviors. Subjects with hypertension subsequently received anti-hypertensive therapy to achieve casual blood pressure (BP)<95th percentile. After 12 months, all parents again completed the BRIEF and CBCL. RESULTS: Twenty-two subjects with hypertension and 25 normotensive control subjects underwent both baseline and 12-month assessments. The BP of subjects with hypertension improved (24-hour systolic BP [SBP] load: mean baseline versus 12-months, 60% versus 25%, P<.001). Parent ratings of executive function improved from baseline to 12 months in the subjects with hypertension (BRIEF Global Executive Composite T-score, Delta=-5.9, P=0.001), but not in the normotensive control subjects (Delta=-0.36, P=.83). In contrast, T-scores on the CBCL Internalizing and Externalizing summary scales did not change significantly from baseline to 12 months in either subjects with hypertension or control subjects. CONCLUSIONS:Children with hypertension demonstrated improvement in parental ratings of executive function after 12 months of anti-hypertensive therapy. Copyright (c) 2010 Mosby, Inc. All rights reserved.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Elaine Urbina; Bruce Alpert; Joseph Flynn; Laura Hayman; Gregory A Harshfield; Marc Jacobson; Larry Mahoney; Brian McCrindle; Michele Mietus-Snyder; Julia Steinberger; Stephen Daniels Journal: Hypertension Date: 2008-08-04 Impact factor: 10.190
Authors: M Soergel; M Kirschstein; C Busch; T Danne; J Gellermann; R Holl; F Krull; H Reichert; G S Reusz; W Rascher Journal: J Pediatr Date: 1997-02 Impact factor: 4.406
Authors: Erik G Willcutt; Alysa E Doyle; Joel T Nigg; Stephen V Faraone; Bruce F Pennington Journal: Biol Psychiatry Date: 2005-06-01 Impact factor: 13.382
Authors: Marc B Lande; Heather Adams; Bonita Falkner; Shari R Waldstein; George J Schwartz; Peter G Szilagyi; Hongyue Wang; Donna Palumbo Journal: J Pediatr Date: 2008-09-27 Impact factor: 4.406
Authors: Cinzia R De Luca; Stephen J Wood; Vicki Anderson; Jo-Anne Buchanan; Tina M Proffitt; Kate Mahony; Christos Pantelis Journal: J Clin Exp Neuropsychol Date: 2003-04 Impact factor: 2.475
Authors: S R Waldstein; J R Jennings; C M Ryan; M F Muldoon; A P Shapiro; J M Polefrone; T V Fazzari; S B Manuck Journal: Health Psychol Date: 1996-03 Impact factor: 4.267
Authors: Stephen R Hooper; Arlene C Gerson; Robert W Butler; Debbie S Gipson; Susan R Mendley; Marc B Lande; Shlomo Shinnar; Alicia Wentz; Matthew Matheson; Christopher Cox; Susan L Furth; Bradley A Warady Journal: Clin J Am Soc Nephrol Date: 2011-07-07 Impact factor: 8.237
Authors: Marc B Lande; Arlene C Gerson; Stephen R Hooper; Christopher Cox; Matt Matheson; Susan R Mendley; Debbie S Gipson; Cynthia Wong; Bradley A Warady; Susan L Furth; Joseph T Flynn Journal: Clin J Am Soc Nephrol Date: 2011-06-23 Impact factor: 8.237
Authors: Marc B Lande; Heather R Adams; Juan C Kupferman; Stephen R Hooper; Peter G Szilagyi; Donald L Batisky Journal: J Am Soc Hypertens Date: 2013-06-20
Authors: Brenda Mendizábal; Elaine M Urbina; Richard Becker; Stephen R Daniels; Bonita E Falkner; Gilad Hamdani; Coral D Hanevold; Stephen R Hooper; Julie R Ingelfinger; Marc Lande; Lisa J Martin; Kevin Meyers; Mark Mitsnefes; Bernard Rosner; Joshua A Samuels; Joseph T Flynn Journal: Hypertension Date: 2018-09 Impact factor: 10.190
Authors: Marc B Lande; Donald L Batisky; Juan C Kupferman; Joshua Samuels; Stephen R Hooper; Bonita Falkner; Shari R Waldstein; Peter G Szilagyi; Hongyue Wang; Jennifer Staskiewicz; Heather R Adams Journal: J Pediatr Date: 2016-09-29 Impact factor: 4.406